Closed · RFA-DK-23-001 · CFDA 93.847 · Discretionary
A Consortium for Gut-Brain Communication in Parkinsons Disease (U24 Clinical Trial not allowed)
Federal grant opportunity posted by National Institutes of Health, cataloged on Grants.gov.
- up to $400K
- Award range
- Closed
- Status
- November 15, 2023
- Close date
- -
- Expected awards
The verdict
A Consortium for Gut-Brain Communication in Parkinsons Disease (U24 Clinical Trial not allowed) is a closed discretionary listing from National Institutes of Health that offered Up to $400,000. Future funding cycles may be published under the same CFDA number.
- up to $400K
- award range
- Closed
- application status
- 93.847
- CFDA program
Opportunity snapshot. This Grants.gov announcement - A Consortium for Gut-Brain Communication in Parkinsons Disease (U24 Clinical Trial not allowed) - is cataloged under number RFA-DK-23-001 and tied to CFDA assistance listing 93.847, posted by National Institutes of Health. Grants.gov currently shows the opportunity as closed, first posted on July 31, 2023 and last updated on August 1, 2023. The funding category is Discretionary, delivered as a cooperative agreement.
Award economics. The award range on file is Up to $400,000. Cost sharing is not required, so applicants do not need to commit matching funds to be competitive on this opportunity. Federal award ranges are often upper bounds; actual allocations reflect program appropriations, the strength of the applicant pool, and the evaluation committee's scoring.
Deadline and action path. This opportunity closed on November 15, 2023. Future funding cycles may be published under the same CFDA number, so monitoring the parent program page is the most reliable way to catch re-announcements. Every Grants.gov submission requires an active SAM.gov registration and a Unique Entity ID. Review the Eligibility section below carefully, federal eligibility categories (nonprofit, state or local government, tribal, individual, educational institution, small business) have distinct registration and reporting requirements. Pre-application outreach to the listed agency contact is permitted and often welcomed, it helps clarify scope and scoring priorities. Before acting on the deadline or award figures above, verify them directly on the official Grants.gov listing, amendments can change dates and amounts after this page was last refreshed.
Award Range
Up to $400,000
Close Date
November 15, 2023
Posted
July 31, 2023
Instrument
Cooperative Agreement
Description
Parkinsons disease (PD) is the second most common and fastest growing neurodegenerative disorder, with approximately 60,000 Americans diagnosed annually. PD symptoms are not limited to motor dysfunction and more than 50% of patients who develop PD often have a history of bowel complaints affecting nearly all parts of the gastrointestinal (GI) system. These SI symptoms often precede the onset of motor symptoms, indicating that GI dysfunction may be an early manifestation of the disease and the gut may be an unexplored diagnostic and/or therapeutic target. The purpose of this Funding Opportunity Announcement (FOA) is to establish a Gut Brain Parkinson's Diesase Consortium (GBPDC) The Data Coordinating Center (DCC) of the GBPDC will coordinate collaboration among the Gastroenterology Neurology Research Centers (GNRCs, as described in the companion FOA, RFA-DK-22-036), enrollment of subjects into the study, submission of data and other biological samples to central repositories, processing of biospeciments, submission of clinical, cellular and molecular data to central databases, and data analysis. The DCC will manage the operations of the GBPDC Steering Committee and other operational committees and provide the infrastructure for the efficient design and conduct of multicenter clinical studies and establishe a repostiory of patient samples that may be used for ancillary studies of etiology and pathogenesis. The DCC will also coordinate the development of pilot projects for rapid follow-up of emerging findings by members of the GBPDC.
Eligibility
Grants.gov lists this opportunity under eligibility category codes 00, 01, 02, 04, 05, 06, 07, 08, 11, 12, 13, 20, 22, 23, 25. These codes correspond to applicant types (state/local government, tribal organization, nonprofit, educational institution, individual, small business, etc.) defined in Grants.gov's own eligibility reference. See the current Grants.gov eligibility categories or check the official listing below for this opportunity's exact eligibility statement.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Parent Grant Program
Diabetes, Endocrine, and Metabolic Disease Research
National Institutes of Health
Agency Contact
NIH Grants Information grantsinfo@nih.gov
Key Dates
Frequently Asked Questions
What is this grant opportunity?
Is this opportunity still open?
How much funding is available?
How do I apply?
More from National Institutes of Health
Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)
Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)
Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required)
Development of Collaborative Research Facilities or Research-Resource Facilities (C06 Clinical Trial Not Allowed)
Research Grants in Clinical Informatics (R01 Clinical Trial Optional)
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
Related
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |